These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8007572)

  • 1. Epidermal growth factor antagonizes vasopressin in vivo and in vitro.
    Phillips PA; Grant SL; Davidson AF; Risvanis J; Stephenson J; Gow CB
    Kidney Int; 1994 Apr; 45(4):1028-36. PubMed ID: 8007572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between epidermal growth factor and arginine vasopressin in renal medullary membranes.
    Grant SL; Phillips PA; Gow CB
    Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):243-7. PubMed ID: 8076430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect.
    Albuquerque CA; Nijland MJ; Ross MG
    J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular effects alter early-gestation fetal renal responses to vasopressin.
    Ervin MG; Terry KA; Calvario GC; Castro R; Ross MG; Leake RD; Fisher DA
    Am J Physiol; 1994 Mar; 266(3 Pt 2):R722-9. PubMed ID: 8160865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
    Ervin MG; Ross MG; Leake RD; Fisher DA
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
    Saito T; Higashiyama M; Nagasaka S; Sasaki S; Saito T; Ishikawa SE
    Kidney Int; 2001 Oct; 60(4):1266-76. PubMed ID: 11576341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist.
    Yamamura Y; Ogawa H; Yamashita H; Chihara T; Miyamoto H; Nakamura S; Onogawa T; Yamashita T; Hosokawa T; Mori T
    Br J Pharmacol; 1992 Apr; 105(4):787-91. PubMed ID: 1387020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
    Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
    Naitoh M; Suzuki H; Murakami M; Matsumoto A; Ichihara A; Nakamoto H; Yamamura Y; Saruta T
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
    Rihakova L; Quiniou C; Hamdan FF; Kaul R; Brault S; Hou X; Lahaie I; Sapieha P; Hamel D; Shao Z; Gobeil F; Hardy P; Joyal JS; Nedev H; Duhamel F; Beauregard K; Heveker N; Saragovi HU; Guillon G; Bouvier M; Lubell WD; Chemtob S
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1009-18. PubMed ID: 19641130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.
    Tsuboi Y; Ishikawa S; Fujisawa G; Okada K; Saito T
    J Endocrinol; 1994 Nov; 143(2):227-34. PubMed ID: 7829988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of testosterone on the rat renal medullary vasopressin receptor concentration and the antidiuretic response.
    Pávó I; Varga C; Szücs M; László F; Szécsi M; Gardi J; László FA
    Life Sci; 1995; 56(14):1215-22. PubMed ID: 7475899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple receptor contributions to ovine fetal cardiovascular responses to vasopressin.
    Ervin MG; Terry KA; Calvario GC; Ross MG; Leake RD; Fisher DA
    Ann N Y Acad Sci; 1993 Jul; 689():504-7. PubMed ID: 8373035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260).
    Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Johnston CI
    Blood Press; 1994 Mar; 3(1-2):137-41. PubMed ID: 8199714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine vasopressin-induced natriuresis in the anaesthetized rat: involvement of V1 and V2 receptors.
    Smith CP; Balment RJ
    J Endocrinol; 1993 Feb; 136(2):283-8. PubMed ID: 8459193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of indomethacin on epidermal growth factor-induced renal responses in sheep.
    Gow CB; Grant SL; Phillips PA
    Clin Exp Pharmacol Physiol; 1997; 24(9-10):680-5. PubMed ID: 9315369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
    Ledderhos C; Mattson DL; Skelton MM; Cowley AW
    Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
    Bernat A; Hoffmann P; Dumas A; Serradeil-le Gal C; Raufaste D; Herbert JM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.